Article

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

eLife · 2025 · Kira A Cozzolino, author Lynn Sanford, author Samuel Hunter, author Kayla Molison, author Benjamin Erickson, author Meaghan CS Courvan, author Taylor Jones, author Deepa Ajit, author Matthew D Galbraith, author Joaquín M Espinosa, author David Bentley, author Mary Ann Allen, author Robin D Dowell, author ([email protected]) Dylan J Taatjes, author ([email protected]) Alan G Hinnebusch, editor Yamini Dalal, senior_editor

Key facts

Title Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
First author Kira A Cozzolino, author Lynn Sanford, author Samuel Hunter, author Kayla Molison, author Benjamin Erickson, author Meaghan CS Courvan, author Taylor Jones, author Deepa Ajit, author Matthew D Galbraith, author Joaquín M Espinosa, author David Bentley, author Mary Ann Allen, author Robin D Dowell, author ([email protected]) Dylan J Taatjes, author ([email protected]) Alan G Hinnebusch, editor Yamini Dalal, senior_editor
Journal eLife
Published Feb 10, 2025
DOI 10.7554/eLife.100197.3
Devices mentioned K202641, K231013, K801913, K832204, K871945, K961896
Product codes mentioned JQW, JTC, QBD, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature